Mark Adams is a venture capital investor at Two Bear Capital who brings an unusual combination of deep operator experience as a former CIO and CTO at genomics companies like Celmatix and Adaptive Biotechnologies, plus quantitative finance expertise from leading AI and data science teams at Bridgewater Associates. He's recognized as a pioneer in genomics and next-generation sequencing who also serves as a mentor in quantum computing programs, positioning him as a go-to investor for founders building data-heavy biotech platforms at the intersection of AI, quantum computing, and life sciences.